Stake enables renters to receive cash back rewards for paying their rent. Stake is on a mission to make renting financially rewarding, build renters’ savings with no fees or debt accumulation, and empower today’s owners to create financially safe and secure rental communities. Stake reduces downtimes and marketing costs while boosting top-line revenue with retention and renewals. Its data-powered rewards lessen the overall cost of incentives and concessions by over 50% and increase leasing velocity by 2x.
Scopio Labs
Series C in 2022
Scopio Labs Ltd. is a company based in Tel Aviv, Israel, that specializes in developing advanced digital microscopes utilizing computational imaging technology. Founded in 2015, Scopio Labs focuses on enhancing diagnostics in hematology by providing innovative tools that enable the analysis of blood samples and bone marrow aspirates. Its products are designed to deliver high-resolution imaging and actionable insights from large volumes of data, facilitating new diagnostic methods for blood-related diseases. The company's equipment supports clinical workflows by offering fully digital applications that improve the efficiency and accuracy of cell morphology assessments, thus enabling faster and more reliable detection and diagnosis of conditions such as cancer and other hematological disorders.
Aptihealth
Series B in 2021
Aptihealth is a behavioral health engagement company focused on enhancing the quality of behavioral healthcare, particularly for underserved populations. It has developed a technology-driven platform that integrates physical and behavioral healthcare through a comprehensive approach. This platform connects medical providers, behavioral health specialists, and patients, utilizing proprietary screening, assessment, and treatment management protocols. By offering personalized care delivery services, Aptihealth aims to streamline the care process and improve patient outcomes. Its digital solution facilitates virtual, integrated care, enabling patients to achieve better mental health more quickly and maintain their well-being over time.
Campfire
Seed Round in 2021
Campfire is a new startup focused on 3D collaboration for design and engineering workflows. Led by pioneers of today’s most well-known augmented reality platforms, Campfire provides a new generation of devices and applications that enable globally distributed teams to work with 3D models as if sharing a central holographic projector.
TytoCare Ltd. is a healthcare technology company that specializes in developing handheld devices and mobile applications for remote medical examinations. Founded in 2011 and headquartered in Netanya, Israel, with an additional office in New York, TytoCare enables users to perform self-examinations and connect with healthcare professionals for on-demand diagnoses and prescriptions. The company's product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care settings. These solutions encompass a modular examination tool that allows users to assess various health parameters, including heart and lung function, skin, throat, ears, and body temperature. TytoCare's platform also features a telehealth system for sharing examination data, conducting live video consultations, and utilizing a cloud-based repository with analytics. With built-in guidance technology and machine learning, TytoCare aims to enhance the accuracy and accessibility of healthcare services. The company maintains a strategic partnership with Novant Health to further its mission of facilitating remote healthcare.
Medasense
Series C in 2020
Medasense is a medical technology company based in Ramat Gan, Tel Aviv, Israel, specializing in pain monitoring solutions. Its flagship product, the PMD-200, utilizes a proprietary non-invasive sensor and artificial intelligence to objectively monitor and quantify a patient's pain response through the NOL index. This unique platform is particularly valuable in operating rooms and critical care settings, where patients are often unable to communicate their pain levels. By providing real-time insights into pain management, the PMD-200 aims to optimize pain control and reduce the risk of overmedication, supporting improved patient safety and outcomes. Medasense's technology also extends to cloud-based solutions for clinics and home care, tapping into a broader market potential. The PMD-200 is distributed in Europe through an exclusive partnership with Medtronic and has received marketing clearance in several regions, including Canada, Latin America, and Australia. Founded in 2008, Medasense continues to focus on enhancing pain management solutions for healthcare providers.
Lemonaid Health
Series B in 2020
Lemonaid Health is an online telemedicine platform founded in 2013 and headquartered in San Francisco, California. The company aims to enhance the patient experience and optimize clinical care by utilizing advancements in machine learning and artificial intelligence. Its platform collects information on medical history, symptoms, current medications, and allergies, applying evidence-based guidelines to provide consumers with prescriptions. By offering healthcare services at a lower cost than typical co-pays, Lemonaid Health strives to make quality medical care more accessible to patients.
Scopio Labs
Series B in 2020
Scopio Labs Ltd. is a company based in Tel Aviv, Israel, that specializes in developing advanced digital microscopes utilizing computational imaging technology. Founded in 2015, Scopio Labs focuses on enhancing diagnostics in hematology by providing innovative tools that enable the analysis of blood samples and bone marrow aspirates. Its products are designed to deliver high-resolution imaging and actionable insights from large volumes of data, facilitating new diagnostic methods for blood-related diseases. The company's equipment supports clinical workflows by offering fully digital applications that improve the efficiency and accuracy of cell morphology assessments, thus enabling faster and more reliable detection and diagnosis of conditions such as cancer and other hematological disorders.
TytoCare
Venture Round in 2020
TytoCare Ltd. is a healthcare technology company that specializes in developing handheld devices and mobile applications for remote medical examinations. Founded in 2011 and headquartered in Netanya, Israel, with an additional office in New York, TytoCare enables users to perform self-examinations and connect with healthcare professionals for on-demand diagnoses and prescriptions. The company's product offerings include TytoHome for consumers, TytoPro for healthcare professionals, and TytoClinic for remote care settings. These solutions encompass a modular examination tool that allows users to assess various health parameters, including heart and lung function, skin, throat, ears, and body temperature. TytoCare's platform also features a telehealth system for sharing examination data, conducting live video consultations, and utilizing a cloud-based repository with analytics. With built-in guidance technology and machine learning, TytoCare aims to enhance the accuracy and accessibility of healthcare services. The company maintains a strategic partnership with Novant Health to further its mission of facilitating remote healthcare.
HyGIeaCare
Series C in 2019
HyGIeaCare, Inc. is a healthcare company based in Austin, Texas, that specializes in providing innovative solutions and services for gastroenterologists to enhance gastrointestinal outcomes for their patients. Founded in 2014 by Gavriel Meron, the company offers the HyGIeaCare Prep system, a prescription medical device designed for colon cleansing, particularly before radiologic or endoscopic examinations. In addition to the prep system, HyGIeaCare operates a network of centers that provide colon cleansing procedures, which can assist patients in preparing for colonoscopy or alleviating symptoms of chronic constipation. Through its services, HyGIeaCare aims to simplify the bowel preparation process and improve the overall patient experience in gastrointestinal care.
Emedgene Technologies Ltd., based in Mazor, Israel, specializes in AI-driven genomics solutions. It offers a platform that automates the interpretation of genetic tests, enabling healthcare professionals to provide personalized care more efficiently. The company collaborates with leading healthcare and life sciences organizations to facilitate precision medicine programs and accelerate research in rare Mendelian diseases.
Harbo Technologies
Series A in 2017
HARBO Technologies Ltd. specializes in solutions for preventing the severe consequences of oil spills. Based in Tel Aviv, Israel, the company was founded in 2012 and has developed the T-Fence immediate booming system, which features a compact vessel that can produce and deploy an offshore containment boom. This system is designed for rapid deployment by as few as two individuals, making it highly effective in responding to spills from various sources, including large ships, oil rigs, ports, and coastal infrastructure. HARBO's solutions cater to a range of sectors such as marine agriculture, oil spill response, and tourism, enabling organizations to mitigate the environmental and economic impacts of oil spills swiftly and efficiently. The lightweight design of the T-Fence system allows for use in remote locations, requiring minimal logistical support for effective operation.
Gauzy, established in 2009, is a global leader in light control glass technology. Headquartered in Tel Aviv, Israel, with operations in the US and Germany, the company specializes in developing, manufacturing, and marketing LCG® (light control glass) technology. Gauzy's innovative products, including SPD and PDLC films, enable glass to transition from transparent to varying degrees of opacity, offering custom shading, solar control, and transparent displays. Their solutions are used in diverse applications such as architecture, automotive, aviation, and consumer electronics, serving global brands like Crowne Plaza, Deloitte, and The Ritz Carlton. Gauzy's global presence includes dedicated production facilities, R&D centers, sales offices, and a network of certified partners, bringing its technology to over 40 countries.
Scopio Labs
Venture Round in 2016
Scopio Labs Ltd. is a company based in Tel Aviv, Israel, that specializes in developing advanced digital microscopes utilizing computational imaging technology. Founded in 2015, Scopio Labs focuses on enhancing diagnostics in hematology by providing innovative tools that enable the analysis of blood samples and bone marrow aspirates. Its products are designed to deliver high-resolution imaging and actionable insights from large volumes of data, facilitating new diagnostic methods for blood-related diseases. The company's equipment supports clinical workflows by offering fully digital applications that improve the efficiency and accuracy of cell morphology assessments, thus enabling faster and more reliable detection and diagnosis of conditions such as cancer and other hematological disorders.
Medasense
Series B in 2016
Medasense is a medical technology company based in Ramat Gan, Tel Aviv, Israel, specializing in pain monitoring solutions. Its flagship product, the PMD-200, utilizes a proprietary non-invasive sensor and artificial intelligence to objectively monitor and quantify a patient's pain response through the NOL index. This unique platform is particularly valuable in operating rooms and critical care settings, where patients are often unable to communicate their pain levels. By providing real-time insights into pain management, the PMD-200 aims to optimize pain control and reduce the risk of overmedication, supporting improved patient safety and outcomes. Medasense's technology also extends to cloud-based solutions for clinics and home care, tapping into a broader market potential. The PMD-200 is distributed in Europe through an exclusive partnership with Medtronic and has received marketing clearance in several regions, including Canada, Latin America, and Australia. Founded in 2008, Medasense continues to focus on enhancing pain management solutions for healthcare providers.
Harbo Technologies
Seed Round in 2016
HARBO Technologies Ltd. specializes in solutions for preventing the severe consequences of oil spills. Based in Tel Aviv, Israel, the company was founded in 2012 and has developed the T-Fence immediate booming system, which features a compact vessel that can produce and deploy an offshore containment boom. This system is designed for rapid deployment by as few as two individuals, making it highly effective in responding to spills from various sources, including large ships, oil rigs, ports, and coastal infrastructure. HARBO's solutions cater to a range of sectors such as marine agriculture, oil spill response, and tourism, enabling organizations to mitigate the environmental and economic impacts of oil spills swiftly and efficiently. The lightweight design of the T-Fence system allows for use in remote locations, requiring minimal logistical support for effective operation.
mPharma
Seed Round in 2016
mPharma is a healthcare company focused on enhancing access to affordable medications in emerging markets. Founded in 2013 by Gregory Rockson, Daniel Shoukimas, and James Finucane, mPharma collaborates with drug manufacturers, insurance providers, financial institutions, and governments to streamline the delivery of prescription drugs to consumers. The company offers a pharmaceutical data analytics platform that assists pharmacies in managing their inventory, prescribing medications, and reporting adverse drug reactions. By ensuring that high-quality chronic disease medications are consistently available at sustainable prices, mPharma aims to improve health outcomes for patients, doctors, and pharmacists alike.
Via Surgical
Series A in 2016
Via Surgical Ltd. is a company focused on developing innovative surgical fixation technologies specifically for mesh placement in hernia repair. Founded in 2011 and based in Amirim, Israel, the company offers the FasTouch system, which features deployable fascial suture fixation. This system is designed to provide a strong and consistent fixation solution that can be easily and rapidly deployed. The unique closed locked-loop suture concept contributes to the fixation strength while minimizing the amount of material used, which may help reduce foreign body response and chronic pain in patients. In addition to hernia repair, Via Surgical's products are applicable in rotator cuff repair, particularly in minimally invasive procedures. The founding team, comprising Lena Levin, Ofek Levin, and Arik Levy, brings a wealth of experience from their previous venture, PolyTouch Medical, where they developed advanced devices for improving surgical accuracy and efficiency.
Scopio Labs
Series A in 2015
Scopio Labs Ltd. is a company based in Tel Aviv, Israel, that specializes in developing advanced digital microscopes utilizing computational imaging technology. Founded in 2015, Scopio Labs focuses on enhancing diagnostics in hematology by providing innovative tools that enable the analysis of blood samples and bone marrow aspirates. Its products are designed to deliver high-resolution imaging and actionable insights from large volumes of data, facilitating new diagnostic methods for blood-related diseases. The company's equipment supports clinical workflows by offering fully digital applications that improve the efficiency and accuracy of cell morphology assessments, thus enabling faster and more reliable detection and diagnosis of conditions such as cancer and other hematological disorders.
CU-BX
Corporate Round in 2015
CU-BX is a health analytics platform focused on enhancing driver safety and comfort through advanced monitoring solutions. The company specializes in providing high-accuracy measurements of various health parameters, including fatigue, stress, heart rate, and respiratory rate. Its patented technology ensures reliable performance across diverse road and lighting conditions and is adaptable to various clothing and accessories. CU-BX collaborates with major automotive stakeholders, including original equipment manufacturers and suppliers, to develop driver monitoring systems and aftermarket solutions. By integrating sophisticated sensors and dashcam data, CU-BX aims to improve in-cabin comfort and promote safer driving practices, making it a key player in the automotive health analytics sector.